These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
677 related articles for article (PubMed ID: 6338896)
1. The cellular content of non Hodgkin lymphomas: a comprehensive analysis using monoclonal antibodies and other surface marker techniques. Habeshaw JA; Bailey D; Stansfeld AG; Greaves MF Br J Cancer; 1983 Mar; 47(3):327-51. PubMed ID: 6338896 [TBL] [Abstract][Full Text] [Related]
2. Surface phenotyping, histology and the nature of non-Hodgkin lymphoma in 157 patients. Habeshaw JA; Catley PF; Stansfeld AG; Brearley RL Br J Cancer; 1979 Jul; 40(1):11-34. PubMed ID: 314300 [TBL] [Abstract][Full Text] [Related]
3. Monoclonal antibody studies in B(non-T)-cell malignancies. Shimoyama M; Minato K; Tobinai K; Nagai M; Hirose M Jpn J Clin Oncol; 1983 Sep; 13(3):477-88. PubMed ID: 6417373 [TBL] [Abstract][Full Text] [Related]
4. Non-Hodgkin's lymphoma phenotyping: problems in the use of heterologous and monoclonal antibodies. Barcos M; Minowada J; Minato K; Pollard C; Cancino M; Han T; Henderson E; Ozer H Leuk Res; 1983; 7(4):523-37. PubMed ID: 6604849 [TBL] [Abstract][Full Text] [Related]
7. Binding of peanut lectin to germinal-centre cells: a marker for B-cell subsets of follicular lymphoma? Rose ML; Habeshaw JA; Kennedy R; Sloane J; Wiltshaw E; Davies AJ Br J Cancer; 1981 Jul; 44(1):68-74. PubMed ID: 6789856 [TBL] [Abstract][Full Text] [Related]
8. SIg-E- ("null-cell") non-Hodgkin's lymphomas. Multiparametric determination of their B- or T-cell lineage. Knowles DM; Dodson L; Burke JS; Wang JM; Bonetti F; Pelicci PG; Flug F; Dalla-Favera R; Wang CY Am J Pathol; 1985 Sep; 120(3):356-70. PubMed ID: 2931028 [TBL] [Abstract][Full Text] [Related]
9. In situ immunologic characterization of follicular lymphomas. Ancelin E; Delsol G; Familiades J; Mason DY; Kuhlein E; Al Saati T; Laurent G; Huguet-Rigal F Hematol Oncol; 1984; 2(3):221-37. PubMed ID: 6384007 [TBL] [Abstract][Full Text] [Related]
10. Immune marker expression in 53 lymphomas of high-grade malignancy. Pallesen G; Madsen M; Schifter S Histopathology; 1983 Nov; 7(6):841-57. PubMed ID: 6689315 [TBL] [Abstract][Full Text] [Related]
11. Analysis of large-cell lymphomas using monoclonal and heterologous antibodies. van der Valk P; van den Besselaar-Dingjan G; Daha MR; Meijer CJ J Clin Pathol; 1983 Jan; 36(1):44-50. PubMed ID: 6337190 [TBL] [Abstract][Full Text] [Related]
12. Diversity of immunological phenotypes of lymphoblastic lymphoma. Cossman J; Chused TM; Fisher RI; Magrath I; Bollum F; Jaffe ES Cancer Res; 1983 Sep; 43(9):4486-90. PubMed ID: 6191861 [TBL] [Abstract][Full Text] [Related]
13. Cell-associated immunoglobulin in human non-Hodgkin lymphomas. A comparative study of surface immunoglobulin on cells in suspension and cytoplasmic immunoglobulin by immunohistochemistry. Landaas TO; Godal T; Marton PF; Kvaløy S; Langholm R; Lindmo T; Jørgensen OG; Høst H Acta Pathol Microbiol Scand A; 1981 Mar; 89(2):91-101. PubMed ID: 7023187 [TBL] [Abstract][Full Text] [Related]
14. Reactivity of Leu 1 and T101 monoclonal antibodies with B cell lymphomas (correlations with other immunological markers). Al Saati T; Laurent G; Caveriviere P; Rigal F; Delsol G Clin Exp Immunol; 1984 Dec; 58(3):631-8. PubMed ID: 6239721 [TBL] [Abstract][Full Text] [Related]
15. Phenotypic analysis by flow cytometry of surface immunoglobulin light chains and B and T cell antigens in lymph nodes involved with non-Hodgkin's lymphoma. Liendo C; Danieu L; Al-Katib A; Koziner B Am J Med; 1985 Oct; 79(4):445-54. PubMed ID: 3931469 [TBL] [Abstract][Full Text] [Related]
16. Characterization of malignant and non-neoplastic cell phenotypes in highly malignant non-Hodgkin lymphomas. Porwit-Ksiazek A; Christensson B; Lindemalm C; Mellstedt H; Tribukait B; Biberfeld G; Biberfeld P Int J Cancer; 1983 Dec; 32(6):667-74. PubMed ID: 6317576 [TBL] [Abstract][Full Text] [Related]
17. Characteristics of Sternberg-Reed, and related cells in Hodgkin's disease: an immunohistological study. Dorreen MS; Habeshaw JA; Stansfeld AG; Wrigley PF; Lister TA Br J Cancer; 1984 Apr; 49(4):465-76. PubMed ID: 6370286 [TBL] [Abstract][Full Text] [Related]
18. [Immunocytologic diagnosis of leukemia and lymphoma: monoclonal antibodies in the differential diagnosis of hematologic neoplasms]. Huber H; Gattringer C; Thaler J; Peschel C Behring Inst Mitt; 1985 Dec; (78):83-117. PubMed ID: 3914283 [TBL] [Abstract][Full Text] [Related]
19. The application of monoclonal antibodies to the characterization and diagnosis of lymphoid neoplasms: a review of recent studies. Knowles DM; Dodson LD; Raab R; Mittler RS; Talle MA; Goldstein G Diagn Immunol; 1983; 1(3):142-9. PubMed ID: 6333955 [TBL] [Abstract][Full Text] [Related]
20. Malignant lymphoma with dual B and T cell markers. Analysis of the neoplastic cells with monoclonal antibodies directed against T cell subsets. Aisenberg AC; Bloch KJ; Wilkes BM J Exp Med; 1981 Nov; 154(5):1709-14. PubMed ID: 6975352 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]